AG
AVNS

Algert Global’s Avanos Medical AVNS Stock Holding History

Algert Global’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$420K Sell
30,011
-54,020
-64% -$728K 0.01% 984
2025
Q4 		$944K Buy
84,031
+12,381
+17% +$142K 0.01% 860
2025
Q3 		$828K Buy
71,650
+10,910
+18% +$128K 0.01% 864
2025
Q2 		$743K Buy
+60,740
New +$764K 0.02% 861
2024
Q3 		– Sell
-66,476
Closed -$1.32M – 1205
2024
Q2 		$1.32M Buy
66,476
+4,646
+8% +$90.5K 0.04% 599
2024
Q1 		$1.23M Buy
61,830
+32,510
+111% +$628K 0.05% 560
2023
Q4 		$658K Buy
+29,320
New +$605K 0.03% 735
2022
Q4 		– Sell
-40,115
Closed -$874K – 1135
2022
Q3 		$874K Buy
40,115
+2,039
+5% +$53.3K 0.05% 597
2022
Q2 		$1.04M Buy
38,076
+18,130
+91% +$521K 0.08% 452
2022
Q1 		$668K Buy
+19,946
New +$642K 0.04% 704
2016
Q4 		– Sell
-9,664
Closed -$335K – 330
2016
Q3 		$335K Buy
+9,664
New +$338K 0.1% 288

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Algert Global's AVNS Position: Q1 2026 in Review

Algert Global reduced its Avanos Medical (AVNS) stake by 64% in Q1 2026, selling an estimated $728K and leaving 30,011 shares worth $420K. The position accounts for 0.01% of the portfolio, ranked #984.

Algert Global first reported a position in AVNS in Q3 2016 and has held it in 11 quarters since. The position peaked at $1.32M in Q2 2024. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Algert Global held 30,011 shares of Avanos Medical worth $420K as of Q1 2026.
  • Algert Global sold 54,020 Avanos Medical shares in Q1 2026, an estimated $728K.
  • Avanos Medical made up 0.01% of Algert Global's portfolio in Q1 2026, its #984 holding.
  • Algert Global first reported a position in Avanos Medical in Q3 2016 and has held it in 11 quarters since.
  • Algert Global's Avanos Medical position peaked at $1.32M in Q2 2024.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.